Cerecor Appoints Interim CEO

Pharmaceutical Investing

Cerecor announced the retirement of its president and CEO Dr. Uli Hacksell.

Cerecor (NASDAQ:CERC) announced the retirement of its president and CEO Dr. Uli Hacksell.
As quoted in the press release:

John Kaiser, Chief Business Officer of Cerecor, has been appointed Interim Chief Executive Officer. Cerecor’s Board of Directors has initiated a search for a permanent Chief Executive Officer. Dr. Hacksell will stay on as Chairman of Cerecor’s Board.
“The recent cash infusions in Cerecor from the equity investment by Armistice Capital in the second quarter of 2017 and the sale of CERC-501 to Janssen that was separately announced today have provided me with the opportunity to leave the day-to-day responsibilities of Cerecor to a new Chief Executive Officer, knowing that I can be optimistic about a bright future for the company,” said Dr. Hacksell. “I will enjoy continuing to participate in guiding the strategic direction of Cerecor as Chairman of the Board.”

Click here to read the full press release.

Source: www.marketwired.com

The Conversation (0)
×